{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:45:15Z","timestamp":1776840315198,"version":"3.51.2"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"\n Objective<\/jats:title>\n To retrospectively investigate the clinical characteristics and etiological spectrum of infantile cholestasis, with an emphasis on evolving diagnostic approaches.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Clinical data of 326 infants diagnosed with infantile cholestasis at the Children's Hospital Affiliated to Shandong University from January 2020 to December 2025 were retrospectively analyzed. Etiological distribution was systematically examined. Serum bile acid profiling was performed for suspected bile acid synthesis defects, and genetic sequencing for unexplained or suspected genetic cholestasis.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Among 326 infants with infantile cholestasis, 56.7% presented with light- or clay-colored stools, 62.9% had hepatomegaly, and 8.3% had comorbidities. The etiological spectrum included biliary tract anomalies [50.6%, including 161 biliary atresia (BA)], genetic metabolic liver diseases (9.8%,\n n<\/jats:italic>\n \u2009=\u200932), infectious causes (7.4%), drug-related causes (3.4%), idiopathic cholestasis (6.7%), other rare causes (0.9%), and undetermined etiology (21.2%). No significant differences in sex or age were observed between the genetic metabolic group (\n n<\/jats:italic>\n \u2009=\u200932) and BA group (\n n<\/jats:italic>\n \u2009=\u2009161) (both\n P<\/jats:italic>\n \u2009&gt;\u20090.05). After excluding 165 surgical cases, genetic testing was performed in 55 of 161 remaining infants (34.2%), with pathogenic or likely pathogenic variants identified in 33 (60.0% detection rate) across 14 genes (e.g.,\n JAG1<\/jats:italic>\n ,\n SLC25A13<\/jats:italic>\n ,\n ABCC2<\/jats:italic>\n ). In an exploratory subgroup analysis (genetic metabolic,\n n<\/jats:italic>\n \u2009=\u200916; BA,\n n<\/jats:italic>\n \u2009=\u200920), the BA subgroup showed significantly higher levels of matrix metalloproteinase-7 (MMP-7), direct bilirubin, and GGT (\n P<\/jats:italic>\n \u2009=\u20090.002 for GGT), with no other significant differences between the two subgroups.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The etiology of infantile cholestasis is complex and highly heterogeneous. Genetic testing improves the diagnostic yield of inherited metabolic liver diseases. Serum bile acid profiling provides metabolomic signatures for etiological differentiation. Conventional liver function tests combined with serum MMP-7 represent a simple, reliable, noninvasive approach for early differentiation of biliary atresia.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fped.2026.1843435","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:47:54Z","timestamp":1776836874000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Etiology and clinical characteristics of infantile cholestasis: a single-center retrospective study of 326 cases"],"prefix":"10.3389","volume":"14","author":[{"given":"Yun-Ping","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital)","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Xia","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital)","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital)","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ying","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital)","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital)","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/MPG.0000000000001334","article-title":"Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the north American society for pediatric gastroenterology, hepatology, and nutrition and the European society for pediatric gastroenterology, hepatology, and nutrition","volume":"64","author":"Fawaz","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.pcl.2017.01.006","article-title":"Neonatal cholestasis","volume":"64","author":"Lane","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"B3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.7499\/j.issn.1008-8830.2010124","article-title":"Clinical characteristics and genetic analysis of infants with intrahepatic cholestasis","volume":"23","author":"Wang","year":"2021","journal-title":"Chin J Contemp Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"100892","DOI":"10.1016\/j.lanepe.2024.100892","article-title":"Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)","volume":"40","author":"Leruez-Ville","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"B5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-024-00533-x","article-title":"Biliary atresia","volume":"10","author":"Tam","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fped.2014.00065","article-title":"Diversity of disorders causing neonatal cholestasis\u2014the experience of a tertiary pediatric center in Germany","volume":"2","author":"Hoerning","year":"2014","journal-title":"Front Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/MPG.0000000000003792","article-title":"Matrix metalloproteinase-7 and osteopontin Serum levels as biomarkers for biliary atresia","volume":"77","author":"Aldeiri","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/HEP.0000000000000827","article-title":"Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large north American cohort","volume":"80","author":"Pandurangi","year":"2024","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mam.2017.03.003","article-title":"Bile acid analysis in human disorders of bile acid biosynthesis","volume":"56","author":"Vaz","year":"2017","journal-title":"Mol Aspects Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.14218\/JCTH.2023.00095","article-title":"Comprehensive bile acid profiling of ABCB4-mutated patients and the prognostic role of taurine-conjugated 3\u03b1,6\u03b1,7\u03b1,12\u03b1-tetrahydroxylated bile acid in cholestasis","volume":"12","author":"Liu","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"342119","DOI":"10.1016\/j.aca.2023.342119","article-title":"A chemical derivatization-based pseudotargeted liquid chromatography-tandem mass spectrometry method for sensitive and high coverage determination of bile acids in human serum","volume":"1287","author":"Xiong","year":"2024","journal-title":"Anal Chim Acta"},{"key":"B13","first-page":"365","article-title":"Regulatory mechanisms of bile acid synthesis and its physiological and pathological functions","volume":"41","author":"Liu","year":"2019","journal-title":"Hereditas"},{"key":"B14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.19538\/j.ek2024040612","article-title":"Genetic analysis and early serum bile acid profile characteristics of 20 infants with intrahepatic cholestasis caused by citrin deficiency","volume":"39","author":"Sun","year":"2024","journal-title":"Chin J Pract Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2023.11.028","article-title":"Genetic cholestasis in children and adults","volume":"80","author":"Nayagam","year":"2024","journal-title":"J Hepatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"108253","DOI":"10.4254\/wjh.v17.i7.108253","article-title":"New hope in treating progressive familial intrahepatic cholestasis in children","volume":"17","author":"Mkarem","year":"2025","journal-title":"World J Hepatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1960152","DOI":"10.1155\/2023\/1960152","article-title":"Progressive familial intrahepatic cholestasis: a descriptive study in a tertiary care center","volume":"2023","author":"Alsohaibani","year":"2023","journal-title":"Int J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1159\/000523937","article-title":"Biallelic novel USP53 splicing variant disrupting the gene function that causes cholestasis phenotype and review of the literature","volume":"13","author":"Gezdirici","year":"2023","journal-title":"Mol Syndromol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1843435\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:47:56Z","timestamp":1776836876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1843435\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":18,"alternative-id":["10.3389\/fped.2026.1843435"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1843435","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1843435"}}